{"nct_id":"NCT00390221","title":"Safety and Efficacy Study of Daclizumab High Yield Process (DAC HYP) to Treat Relapsing-Remitting Multiple Sclerosis","status":"COMPLETED","status_verified_date":"2016-05","start_date":"2008-02","start_date_type":null,"primary_completion_date":"2011-05","primary_completion_date_type":"ACTUAL","completion_date":"2011-08","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["BIIB"]}